Pheochromocytoma clinical trials at UCSF
1 in progress, 0 open to eligible people
Showing trials for
Compassionate Use of 131I-MIBG for Patients With Malignant Pheochromocytoma
Sorry, not accepting new patients
This is a compassionate use protocol to allow palliative therapy for patients with malignant pheochromocytoma and paragangliomas.
San Francisco, California
Our lead scientists for Pheochromocytoma research studies include Paul Fitzgerald, MD.
Last updated: